
|Articles|November 1, 2006
Part D puts PBMs in the political spotlight
The emergence of pharmacy benefit management companies (PBMs) as major players in drug benefit design and pricing has generated criticism as well as praise. PBMs previously served as drug benefit administrators for employers and other payers. But as sponsors of Medicare Prescription Drug Plans (PDPs), they now assume risk and design coverage and payment options.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Researchers Urge Payers to Encourage, not Inhibit, Biosimilar Competition
2
Challenges & Solutions behind post-acute care models with OneHome's Noel Gilliam
3
Izervay Continued to Show Benefit in Geographic Atrophy in Open-Label Study
4
COVID-19 may increase the risk of shingles for some, Japanese study finds
5



















































